All News

Dr. Alexander Vaccaro becomes SmartCEO Magazine’s CEO of the Year: 5 key highlights

By Laura Dyrda SmartCEO Magazine named Alexander Vaccaro, MD, PhD, MBA, CEO of the Year in Philadelphia. Dr. Vaccaro assumed the Rothman Institute President position in 2014. The practice has grown significantly over the past five years and continues to participate

Metal Allergy Not Necessarily a Deal Breaker for Implants

By Kate Johnson SAN ANTONIO — Allergists are frustrated by the lack of consensus in the surgical community about metal hypersensitivity in patients in need of a surgical implant, new research indicates. “Most of the specialists in our survey acknowledged

SI-BONE, Inc.® Announces iFuse Implant System® Receives Indication Cleared by the FDA that Includes Improved Pain, Patient Function and Quality of Life at 12-Months

SAN JOSE, Calif., Nov. 9, 2015 /PRNewswire/ — SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant System, a minimally invasive surgical (MIS) device indicated for fusion for certain disorders of the sacroiliac (SI) joint, announced that

KATOR Granted US Patent for Innovative Suture Anchor Technology

LOGAN, Utah, Nov. 9, 2015 /PRNewswire/ — KATOR, a start-up medical device company focused on advanced tissue-to-bone reattachment systems, announced today that the United States Patent and Trademark Office has recently granted the company a key patent related to its innovative suture

New Midcarpal Modular Wrist Hemiarthroplasty Implant to be Released December 2015

November 5, 2015 – Parsippany, NJ – Extremity Medical, LLC announced the scheduled release of the new KinematX Modular Hemi Wrist System to several international surgical facilities in the European Union and Australia by early December 2015. Patient follow-up results

Mainstay Medical – Interim Management Statement

Dublin, Ireland – 9 November 2015: Mainstay Medical International plc (Mainstay or the Company, Euronext Paris: MSTY.PA and ESM of the Irish Stock Exchange: MSTY.IE), a medical device company focused on bringing to market ReActiv8®, an implantable neurostimulation system to

Hemoglobin reduction, total blood loss similar between oral and intravenous TXA use in primary TKA

DALLAS — Data presented here at the American Association of Hip and Knee Surgeons Annual Meeting indicated both hemoglobin reduction and total blood loss were comparable between patients who were administered tranexamic acid either orally or intravenously during primary total

Chondroitin sulfate superior to celecoxib for cartilage loss reduction in patients with knee OA

SAN FRANCISCO ─ Chondroitin sulfate is superior to celecoxib in the reduction of long-term progression of structural changes in knee osteoarthritis, and both treatments were equal in the reduction of the symptoms of osteoarthritis, according to a study presented here

Proximal, not distal fractures, associated with premature mortality in older men, women

By Shirley Pulawski SAN FRANCISCO — Although research presented here at the American College of Rheumatology Annual Meeting showed proximal fractures were associated with premature mortality of older men and women, distal fractures were not associated with this outcome. “Health

Surgical approach in THA did not influence postoperative anteversion change

By Casey Tingle Performing total hip arthroplasty through either the posterolateral or direct anterior approach did not affect postoperative anteversion change; however, the type of approach did affect stem sagittal alignment, according to study result…

© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1